Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=iemt20 Expert Opinion on Drug Metabolism & Toxicology ISSN: 1742-5255 (Print) 1744-7607 (Online) Journal homepage: http://www.tandfonline.com/loi/iemt20 Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors Elnaz Faghfuri, Shekoufeh Nikfar, Kamal Niaz, Mohammad Ali Faramarzi & Mohammad Abdollahi To cite this article: Elnaz Faghfuri, Shekoufeh Nikfar, Kamal Niaz, Mohammad Ali Faramarzi & Mohammad Abdollahi (2018): Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors, Expert Opinion on Drug Metabolism & Toxicology, DOI: 10.1080/17425255.2018.1432593 To link to this article: https://doi.org/10.1080/17425255.2018.1432593 Accepted author version posted online: 24 Jan 2018. Submit your article to this journal View related articles View Crossmark data